Search results for "MEDLINE"

showing 10 items of 2097 documents

Update of the statements on biology and clinical impact of occult hepatitis B virus infection

2019

In October 2018 a large number of international experts with complementary expertise came together in Taormina to participate in a workshop on occult hepatitis B virus infection (OBI). The objectives of the workshop were to review the existing knowledge on OBI, to identify issues that require further investigation, to highlight both existing controversies and newly emerging perspectives, and ultimately to update the statements previously agreed in 2008. This paper represents the output from the workshop.

0301 basic medicineOccult HBV infectionHepatitis B virusmedicine.medical_specialtyCarcinoma HepatocellularHepatocellular carcinomaHbv reactivationMEDLINEHBV reactivationOBImedicine.disease_cause03 medical and health sciences0302 clinical medicineHBV S variantRisk FactorsmedicineHumansHepatitis B AntibodiesIntensive care medicineComputingMilieux_MISCELLANEOUSHepatitis B virusHepatitis B Surface AntigensHepatologyHBV cccDNALiver Neoplasmsvirus diseasesHBV cccDNA; HBV reactivation; HBV S variants; HBV transmission; Hepatocellular carcinoma; OBI; Occult HBV infectionHBV S variantsHepatitis Bmedicine.diseaseOccultdigestive system diseases3. Good healthHBV S variants; HBV cccDNA; HBV reactivation; HBV transmission; Hepatocellular carcinoma; OBI; Occult HBV infection030104 developmental biologyLiverHepatocellular carcinomaDNA Viral030211 gastroenterology & hepatologyHBV transmission[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Recommendations for the implementation of BRCA testing in the care and treatment pathways of ovarian cancer patients

2016

In the last 20 years, following the identification of the BRCA1 and BRCA2 genes (hereinafter referred to as the BRCA genes), preventive pathways have been developed for the identification and clinical management of individuals at high risk of developing breast and ovarian cancer due to the presence of a pathogenic variant in either of these genes. These pathways are aimed at educating high-risk subjects on programs targeted toward early diagnosis and cancer risk reduction. The approval of a novel class of drugs, the PARP enzyme inhibitors, for the treatment of ovarian cancer patients carrying high-risk BRCA pathogenic variants has changed this scenario. BRCA testing, in addition to providin…

0301 basic medicineOncologyCancer ResearchGenes BRCA2Genes BRCA1Brca testingBRCA1; BRCA2; genetic testing; germline mutations; ovarian cancer; PARP inhibitors; somatic mutations; Oncology; Cancer ResearchSettore MED/03 - GENETICA MEDICA0302 clinical medicineClinical decision makingInformed consentsomatic mutationBRCA1 BRCA2 genetic testing germline mutations somatic mutations ovarian cancer PARP inibitorsDisease management (health)PARP inhibitorsOvarian NeoplasmsTumorInformed Consentmedicine.diagnostic_testDisease ManagementGeneral MedicinePrognosisBRCA1; BRCA2; genetic testing; germline mutations; ovarian cancer; PARP inhibitors; somatic mutations; Biomarkers Tumor; Clinical Decision-Making; Disease Management; Female; Genes BRCA1; Genetic Variation; Germ-Line Mutation; Humans; Informed Consent; Mutation; Ovarian Neoplasms; Prognosis; Genes BRCA2; Genetic Testing; Oncology; Cancer Researchovarian cancergermline mutationOncology030220 oncology & carcinogenesisgermline mutationsFemaleHumanmedicine.medical_specialtyPrognosiClinical Decision-MakingMEDLINEgenetic testing03 medical and health sciencesPARP inibitorsInternal medicinemedicineBiomarkers TumorHumansGerm-Line MutationGenetic testingGynecologyBRCA1; BRCA2; PARP inhibitors; genetic testing; germline mutations; ovarian cancer; somatic mutationsbusiness.industryOvarian NeoplasmGenetic Variationmedicine.diseaseBRCA1BRCA2030104 developmental biologyPARP inhibitorGenesMutationsomatic mutationsOvarian cancerbusinessBiomarkers
researchProduct

Is There an Association between β-Carotene and Breast Cancer? A Systematic Review on Breast Cancer Risk

2020

It is suspected that diet influences the risk of developing breast cancer. Several β-carotenoids have been inversely associated with breast cancer risk, but association by type of tumor and participant characteristics remain nuclear. The objective of this review of epidemiological studies is to investigate the relationship between β-carotenoids and breast cancer. This review covers the 2014-2020 period and was carried out using the PubMed and EMBASE databases. Only epidemiological studies carried out on β-carotenoids and breast cancer were included. The initial keyword search yielded 1559 results and finally a total of 28 studies were included. The quality of the articles and the risk of bi…

0301 basic medicineOncologyCancer Researchmedicine.medical_specialtymedicine.medical_treatmentMEDLINEMedicine (miscellaneous)Breast Neoplasms03 medical and health sciences0302 clinical medicineBreast cancerRisk FactorsInternal medicineEpidemiologymedicineHumans030109 nutrition & dieteticsNutrition and DieteticsKeyword searchbusiness.industryDietary intakeCarotenebeta Carotenemedicine.diseaseCarotenoidsDietOncology030220 oncology & carcinogenesisFemalebusinessNutrition and Cancer
researchProduct

Immunotherapy is not for all comers in chemotherapy-refractory advanced gastric cancer. Better predictive biomarkers are needed

2018

0301 basic medicineOncologyChemotherapymedicine.medical_specialtybusiness.industrymedicine.medical_treatmentMEDLINEHematologyImmunotherapyAdvanced gastric cancer03 medical and health sciences030104 developmental biology0302 clinical medicineOncologyRefractory030220 oncology & carcinogenesisInternal medicineMonoclonalmedicineEsophagogastric junctionbusinessPredictive biomarkerAnnals of Oncology
researchProduct

Neoadjuvant score in locally advanced rectal cancer: integrating downstaging in risk assessment and looking for new valuable end points

2018

0301 basic medicineOncologyDisease free survivalmedicine.medical_specialtyColorectal cancermedicine.medical_treatmentLocally advancedMEDLINERectumRisk AssessmentDisease-Free Survival03 medical and health sciences0302 clinical medicineText miningInternal medicineHumansMedicineNeoadjuvant therapyRectal Neoplasmsbusiness.industryRectumHematologymedicine.diseaseNeoadjuvant Therapy030104 developmental biologymedicine.anatomical_structureOncology030220 oncology & carcinogenesisbusinessRisk assessmentAnnals of Oncology
researchProduct

Schlafen-11 (SLFN11): a step forward towards personalized medicine in small-cell lung cancer?

2018

Purpose Both temozolomide (TMZ) and poly (ADP-ribose) polymerase (PARP) inhibitors are active in small-cell lung cancer (SCLC). This phase II, randomized, double-blind study evaluated whether addition of the PARP inhibitor veliparib to TMZ improves 4-month progression-free survival (PFS). Patients and Methods A total of 104 patients with recurrent SCLC were randomly assigned 1:1 to oral veliparib or placebo 40 mg twice daily, days 1 to 7, and oral TMZ 150 to 200 mg/m

0301 basic medicineOncologyMaleLung NeoplasmsDNA Mutational AnalysisPoly (ADP-Ribose) Polymerase-1Placebos0302 clinical medicineAntineoplastic Combined Chemotherapy ProtocolsPromoter Regions GeneticDNA Modification MethylasesAged 80 and overStandard treatmentNuclear ProteinsMiddle AgedNeoplastic Cells CirculatingImmunohistochemistryhumanitiesEditorialOncology030220 oncology & carcinogenesisFemaleNon small cellAdultmedicine.medical_specialtyMEDLINEAggressive disease03 medical and health sciencesText miningDouble-Blind MethodInternal medicinemedicineBiomarkers TumorTemozolomideHumansLung cancerneoplasmsAntineoplastic Agents AlkylatingAgedbusiness.industryTumor Suppressor ProteinsDNA Methylationmedicine.diseaseSmall Cell Lung Carcinomarespiratory tract diseases030104 developmental biologyDNA Repair EnzymesBenzimidazolesPersonalized medicinebusiness
researchProduct

Gender medicine and oncology: report and consensus of an ESMO workshop.

2019

Background: The importance of sex and gender as modulators of disease biology and treatment outcomes is well known in other disciplines of medicine, such as cardiology, but remains an undervalued issue in oncology. Considering the increasing evidence for their relevance, European Society for Medical Oncology decided to address this topic and organized a multidisciplinary workshop in Lausanne, Switzerland, on 30 November and 1 December 2018.

0301 basic medicineOncologyMalemedicine.medical_specialtypopulation pharmacokinetic analysissuperior survivalDecision MakingMEDLINElymphomaDiseaseclearanceMedical Oncology03 medical and health sciences0302 clinical medicinerituximabInternal medicineNeoplasmsPhysiciansEpidemiologymedicinegendermelanomasexcancerHumansDosingfemale-patientsSex Characteristicsbusiness.industrygender medicineCancerHematologymedicine.diseaseChemotherapy regimenClinical trial030104 developmental biologyTreatment Outcome030220 oncology & carcinogenesisoncologyimpactBody CompositionFemalepharmacologybusinesssex-differencesSex characteristicsAnnals of oncology : official journal of the European Society for Medical Oncology
researchProduct

Exosomes in lung cancer liquid biopsies: Two sides of the same coin?

2017

LETTER TO EDITOR

0301 basic medicineOncologyPulmonary and Respiratory Medicinemedicine.medical_specialtyPathologyCancer ResearchLung NeoplasmsMEDLINEExosomes03 medical and health sciences0302 clinical medicineInternal medicinemedicineBiomarkers TumorHumansLiquid biopsyLung cancerbusiness.industryLiquid Biopsymedicine.diseaseMicrovesicles030104 developmental biologyOncology030220 oncology & carcinogenesisHuman medicinebusinessOncology; Pulmonary and Respiratory Medicine; Cancer Research
researchProduct

Extra-nodal extension is an important prognostic parameter for both colonic and rectal cancer.

2016

0301 basic medicineOncologymedicine.medical_specialtyLymphatic metastasisColorectal cancerMEDLINE03 medical and health sciences0302 clinical medicineExtranodal extensionInternal medicinecolonic and rectal cancermedicineHumansRectal Neoplasmsbusiness.industryExtranodal ExtensionHematologyPrognosismedicine.disease030104 developmental biologyOncologyLymphatic Metastasis030220 oncology & carcinogenesisColonic NeoplasmsOncology; Hematologybusiness
researchProduct

The Interplay between Genes and Psychosocial Home Environment on Physical Activity

2018

Introduction Genetic factors contribute to individual differences in physical activity, but it remains uncertain whether the magnitude of the genetic effects is modified by variations in home environments. We aimed to examine to what extent the psychosocial home environment in childhood and adolescence modifies the genetic influences on leisure time physical activity in young adulthood. Methods Participants were Finnish twins (N = 3305) who reported their leisure time physical activity at age 24 yr. The psychosocial home environment was assessed by twins at ages 12, 14, and 17 yr, as well as by their parents when the twins were age 12 yr. Gene–environment interaction modeling was performed …

0301 basic medicineParentsDevelopmental psychology0302 clinical medicineSurveys and QuestionnairesOrthopedics and Sports Medicine030212 general & internal medicineLongitudinal StudiesGene–environment interactionta315Childta515Finlandexerciseta3142twinsFamily Relationsgeneettiset tekijätPsychologyPsychosocialfyysinen aktiivisuusinorganic chemicalsAdolescentlongitudinalPhysical activityMEDLINEPhysical Therapy Sports Therapy and Rehabilitationpsykososiaaliset tekijätpitkittäistutkimushome atmospherecomplex mixturesArticle03 medical and health sciencesFamily relationsLeisure ActivitiesHumansExercisechildhoodnuoret aikuisetkaksostutkimusHome environmentExtramuralfungilapsuusequipment and suppliesTwin studykotiympäristökaksoset030104 developmental biologybacteriaGene-Environment Interactionadolescence
researchProduct